Form 4: InMed CEO's Stock Options Expire
Insider Transaction Report
InMed Pharmaceuticals Inc. CEO Eric A. Adams reported the expiration of 250 employee stock options on December 15, 2025.
Summary
- Eric A. Adams, President & CEO and Director of InMed Pharmaceuticals Inc., filed a Form 4 to report changes in beneficial ownership.
- The filing details the expiration of 250 employee stock options.
- These options had an exercise price of $1,397.97 per share, converted from C$1,925.00 using an exchange rate of C$1.3770 = $US1.00.
- The options were exercisable from December 16, 2020, and expired on December 15, 2025.
- Following this expiration, Eric A. Adams beneficially owns 14,050 derivative securities.
Sentiment
Score: 5
Explanation: Neutral, as this is a routine reporting of an option expiration. While the expiration without exercise could be seen as a minor negative, the filing itself does not provide sufficient context for a strong positive or negative sentiment.
Negatives
- The expiration of 250 employee stock options without exercise suggests they may have been out-of-the-money or not deemed valuable enough to exercise by the CEO, reducing potential future share ownership.
Future Outlook
No forward-looking statements or guidance are provided in this filing.
Industry Context
This filing is a routine insider transaction report and does not provide specific information related to broader industry trends or competitive landscape.
Stakeholder Impact
- Slightly reduces potential future dilution for shareholders as 250 options are no longer exercisable.
- Reduces the number of derivative securities held by the CEO by 250.
Key Dates
| Date | Description |
|---|---|
| 12/16/2020 | Date employee stock options became exercisable. |
| 12/15/2025 | Date of option expiration and transaction date reported. |
Keywords
InMed Pharmaceuticals, INM, Eric A. Adams, Form 4, Stock Options, Beneficial Ownership, CEO, Director, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.